Semax + Selank Nootropic Research Stack ACTH/MC4R Neuropeptide + GABAergic Anxiolytic · Complementary Cognitive Research · ≥99% HPLC · Janoshik COA
Semax (ACTH 4-10 heptapeptide analogue) and Selank (tuftsin-derived hexapeptide) are the two most-researched Russian neuropeptides, operating through complementary mechanisms. Semax upregulates BDNF/NGF via MC4R signaling; Selank modulates GABA-A and stabilizes enkephalin against degradation. Research combines them for simultaneous cognitive enhancement and anxiolytic pathway coverage. QSC stocks both at ≥99% HPLC with Janoshik independent COA.
Why combine Semax and Selank in nootropic research?
Semax targets MC4R → BDNF/NGF upregulation for cognitive enhancement and neuroprotection. Selank targets GABA-A and enkephalin stability for anxiolytic effects. The mechanisms are non-overlapping: one addresses neurotrophic factor expression, the other addresses GABAergic transmission and anxiety pathways. Combined research protocols study both axes simultaneously.
Is Selank addictive?
Selank shows zero physical dependence in preclinical models — it modulates GABA-A via a mechanism distinct from benzodiazepines (which act at the benzodiazepine binding site). Selank does not bind the benzodiazepine site. Preclinical data shows no tolerance development or withdrawal effects at standard research doses. Research use only.
Does QSC stock both Semax and Selank?
Yes — QSC stocks Semax, NA-Semax Amidate, and Selank at ≥99% HPLC with Janoshik independent COA. All verifiable at verify.janoshik.com. Research use only.
Buy Semax + Selank Nootropic Research Stack Components
Both compounds available at ≥99% HPLC · Janoshik Independent COA · verify.janoshik.com
Research Use Only: All QSC products sold strictly for in vitro laboratory research. Not for human or veterinary use. Information on this page is educational and does not constitute medical advice.
